We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

60 hedge funds and large institutions have $122M invested in Sutro Biopharma in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

0.13% more ownership

Funds ownership: 5.03% → 5.16% (+0.13%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $128M → $122M (-$6.16M)

6% less funds holding

Funds holding: 64 → 60 (-4)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
60
Holders Change
-4
Holders Change %
-6.25%
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
2
Increased
29
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.2M
2
Barclays
Barclays
United Kingdom
+$2.22M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$1.49M
4
BI
BVF Inc
California
+$1.37M
5
Victory Capital Management
Victory Capital Management
Texas
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
VM
VV Manager
Massachusetts
-$5.58M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.89M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$655K
4
BCM
Bridgeway Capital Management
Texas
-$629K
5
OAM
Oxford Asset Management
United Kingdom
-$424K
Name Holding Trade Value Shares
Change 		Change in
Stake
GPCM
26
Granite Point Capital Management
Massachusetts
$721K -$309K -2,936 -29%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$668K +$2.1K +20 +0.3%
DCM
28
DAFNA Capital Management
California
$408K – – –
N
29
Nuveen
North Carolina
$403K +$128K +1,220 +45%
Squarepoint
30
Squarepoint
New York
$402K +$121K +1,155 +42%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$295K +$105 +1 +0%
Millennium Management
32
Millennium Management
New York
$270K -$71.7K -682 -20%
Charles Schwab
33
Charles Schwab
California
$231K – – –
PAM
34
Panagora Asset Management
Massachusetts
$227K +$227K +2,158 +3,083%
Bank of America
35
Bank of America
North Carolina
$220K -$61.6K -586 -21%
Wells Fargo
36
Wells Fargo
California
$218K +$21.4K +204 +11%
Creative Planning
37
Creative Planning
Kansas
$217K – – –
OAM
38
Oxford Asset Management
United Kingdom
$201K -$424K -4,032 -67%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$173K +$2.1K +20 +1%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$171K +$5.25K +50 +3%
SIM
41
Spark Investment Management
New York
$148K -$42.1K -401 -22%
Goldman Sachs
42
Goldman Sachs
New York
$142K +$25.2K +240 +21%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$141K – – –
Russell Investments Group
44
Russell Investments Group
United Kingdom
$113K +$3.78K +36 +3%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$112K – – –
UBS Group
46
UBS Group
Switzerland
$68K -$71.8K -683 -51%
AIG
47
American International Group
New York
$66K -$3.89K -37 -5%
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$65K +$13.8K +131 +26%
APA
49
American Portfolios Advisors
New York
$35.4K +$13.7K +130 +60%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$34.5K +$9.98K +95 +39%
1
2
3

STRO Hedge Fund Activity: Q1 2020 in Review

60 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q1 2020, worth a combined $122M — down 4.8% from $128M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of STRO and 2 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 29 added.

The largest buyer was Adage Capital Partners, adding an estimated $4.2M. The largest seller was VV Manager, cutting an estimated $5.58M.

  • 60 institutional investors held Sutro Biopharma (STRO) as of Q1 2020, down from 64 in Q4 2019.
  • Funds reported $122M of Sutro Biopharma stock for Q1 2020, down 4.8% quarter-over-quarter.
  • 2 funds opened new Sutro Biopharma positions in Q1 2020 and 5 closed out, a net change of -3 holders.
  • The largest Sutro Biopharma buyer in Q1 2020 was Adage Capital Partners, an estimated $4.2M added.
  • The largest Sutro Biopharma seller in Q1 2020 was VV Manager, an estimated $5.58M sold.

Based on aggregated 13F filings for Q1 2020.